Background and purpose: Neurons with atrophic neurites may remain alive and therefore may have the potential to regenerate even when neuronal death has occurred in some parts of the brain. This study aimed to explore effects of drugs that can facilitate the regeneration of neurites and the reconstruction of synapses even in severely damaged neurons. Experimental approach: We investigated the effects of extracts of Astragalus mongholicus on the cognitive defect in mice caused by injection with the amyloid peptide . We also examined the effect of the extract on the regeneration of neurites and the reconstruction of synapses in cultured neurons damaged by . Key results: A. mongholicus extract (1 g kg À1 day À1 for 15 days, p.o.) reversed Ab(25-35)-induced memory loss and prevented the loss of axons and synapses in the cerebral cortex and hippocampus in mice. Treatment with Ab(25-35) (10 mM) induced axonal atrophy and synaptic loss in cultured rat cortical neurons. Subsequent treatment with A. mongholicus extract (100 mg/ ml) resulted in significant axonal regeneration, reconstruction of neuronal synapses, and prevention of Ab(25-35)-induced neuronal death. Similar extracts of A. membranaceus had no effect on axonal atrophy, synaptic loss, or neuronal death. The major known components of the extracts (astragalosides I, II, and IV) reduced neurodegeneration, but the activity of the extracts did not correlate with their content of these three astragalosides. Conclusion and implications: A. mongholicus is an important candidate for the treatment of memory disorders and the main active constituents may not be the known astragalosides. Keywords: dementia; axon; synapse; neuronal death; Astragali radix; Astragalus mongholicus; astragalosides; morris water maze; Abbreviations: NF-H, neurofilament-H; NGF, nerve growth factor
Introduction
In addition to the death of neurons, atrophy of neurites and loss of synapses are the major causes of dysfunctions of the brain including Alzheimer's (DeKosky and Scheff, 1990; Terry et al., 1991; Dickson and Vickers, 2001 ), Parkinson's, Huntington and Creutzfeldt-Jakob diseases (Jackson et al., 1995; Liberski and Budka, 1999; Mattila et al., 1999) . Neurons with atrophic neurites may remain alive and therefore may have the potential to regenerate even when neuronal death has occurred in some parts of the brain. We have hypothesized that reconstructing neuronal networks in the injured brain is essential for the recovery of brain function . To reconstruct neuronal networks, neurites must be regenerated and synapses must be reconstructed. In the current studies, we explored the in vitro and in vivo effects of drugs that can facilitate the regeneration of neurites and the reconstruction of synapses even in severely damaged neurons.
Astragali radix (the root of Astragalus mongholicus Bunge or A. membranaceus Bunge) is used mainly as a tonic agent in traditional Chinese and Japanese Kampo medicine. A few reports show that Astragali Radix extract or its components can affect brain function. For example, Astragali Radix extract can upregulate muscarinic acetylcholine receptors in senile rats (Shi et al., 2001) . Also, a mixture of astragalosides, the major components of Astragali Radix, can improve memory in aged mice (Lei et al., 2003) , and astragaloside IV can reduce brain infarction in mice after focal ischemia (Luo et al., 2004) . Despite these reports, the effect of Astragali Radix extract in Alzheimer's disease models has not been assessed and how it reverses memory dysfunction has not been determined.
Amyloid b (Ab) is thought to be a major pathological cause of Alzheimer's disease. Although not found in Alzheimer's brain tissue, ) is a partial fragment of Ab that similarly forms a b-sheet structure (Pike et al., 1995) and induces neuronal cell death (Yankner et al., 1990; Pike et al., 1995) , neurite atrophy (Grace et al., 2002; Tohda et al., 2004) , synaptic loss (Grace et al., 2002; Tohda et al., 2003 Tohda et al., , 2004 and memory impairment (Maurice et al., 1996; Tohda et al., 2003 Tohda et al., , 2004 . We previously showed that mice injected with suffer from memory impairment and neurite and synaptic atrophy (Tohda et al., 2003 (Tohda et al., , 2004 Kuboyama et al., 2005 Kuboyama et al., , 2006 .
In this study, we have investigated the effects of A. mongholicus extract on the cognitive defect in mice caused by injection of . We also examined the effect of the extract on the regeneration of neurites and the reconstruction of synapses in cultured neurons damaged by .
Methods

Preparation of extracts
The aqueous extract of A. mongholicus (Uchida Wakan-yaku, Tokyo, Japan) was prepared as follows. Fifty grams of powdered Astragalis radix were placed in 600 ml water, and boiled for 1 h. The decoction was evaporated under reduced pressure and freeze-dried to obtain 16.23 g of extract powder. This extract was dissolved in tap water for animal experiments. The extract was given orally (1 g kg
À1
, 400 ml). The methanol extracts of A. mongholicus (Uchida Wakan-yaku) and A. membranaceus (Tochimoto Tenkaido, Osaka, Japan) were prepared as follows. Fifty grams of the preparation of radix from each plant were extracted in methanol (500 ml Â 2) for (36 h and 24 h) at room temperature. The combined supernatants were evaporated to obtain the methanol extracts. The extracts were dissolved in dimethyl sulphoxide (DMSO) for primary culture experiments.
Animals
Conditions. Male ddY mice (8 weeks old, Japan SLC, Shizuoka, Japan) were housed with free access to food and water, and were kept in a constant environment (22721C, 5075% humidity, 12-h light cycle starting at 07:00). Animals were handled in accordance with the Guidelines for the Care and Use of Laboratory Animals of the University of Toyama, and all protocols were approved by the Animal Care Committee of the University of Toyama.
Treatments. was dissolved in saline at a concentration of 5 mM and incubated at 371C for 4 days to allow for fibril formation. The mice were anesthetized with chloral hydrate (375 mg kg À1 , i.p.), and Ab(25-35) (25 nmol) or the vehicle (saline) was injected into the right ventricle, with stereotaxic coordinates from the Bregma being, in mm, A À0.22, L À1.0 and V 2.5. Seven days after an intracerebroventricular (i.c.v.) injection of , the aqueous water extract of A. mongholicus (1 g kg À1 day À1 ) or the vehicle (tap water) was administered orally once daily for 15 days.
Water maze test White-colored water was poured into a circular pool (diameter, 120 cm; height, 28 cm), and a white platform (diameter, 12 cm) was placed 1.2 cm below the water level in the middle of a fixed quadrant. The water temperature was adjusted to 21-231C. Training trials were performed four times daily for 7 days to reach a steady escape latency. Briefly, at 1.5 h after p.o. administration of the drug, the mice were allowed to swim freely for 60 s and were left for an additional 30 s on the platform. The interval during four trials was 90 min. The pattern of the start positions in each trial was changed every day. Mice failing to find the platform were manually placed on the platform. Memory-retention tests were performed 7 days after the last training session, that is, 7 days after the discontinuation of p.o. administration of the drugs. The platform was removed, and each mouse was allowed a free 60-s swim. The number of crossings over the point where the platform had been located was counted by video recorder replay.
Immunohistochemistry
Three days after the retention test, the mice were killed by decapitation. The brains were quickly removed from the skull, and frozen in powdered dry ice. The brains were cut in 12-mm coronal sections using a cryostat (CM3050S, Leica, Heidelberg, Germany). The slices were fixed by 4% paraformaldehyde and stained with a monoclonal antibody to phosphorylated neurofilament-H (NF-H) or synaptophysin. Alexa Fluor 488-conjugated goat anti-mouse immunoglobulin (Ig)G was used as the secondary antibody. The fluorescence images were captured using a fluorescence microscope (AX-80, Olympus, Tokyo, Japan) at 662 Â 880 mm, and three sets of serial brain slices from three mice were used to capture the images for each treatment. The areas positive for phosphorylated NF-H or synaptophysin were measured in five brain regions (ATTO densitograph, ATTO, Tokyo, Japan). In each region, the measuring points were randomly selected as 20 squares of 41.5 Â 41.5 mm.
Primary culture of cortical neurones Embryos were removed from pregnant Sprague-Dawley rats (Japan SLC) at 18 days of gestation. The cortices were dissected and the dura mater was removed. The tissues were minced and dissociated, and were then grown in cultures with Neurobasal medium including 12% horse serum on eight-well chamber slides (Falcon, Franklin Lakes, NJ, USA) coated with poly-D-lysine at 371C in a humidified incubator with 10% CO 2 . When or other compounds were added, half of the medium in each well was replaced with fresh medium containing 2% B-27 supplement without serum. In cases of long-term culture (for synaptophysin staining), half of the medium in each well was replaced every 7 days with serum-free medium containing the 2% B-27 supplement after initiation of the culture period. The time schedules of the experiments are shown below each Figure. Analysis of axonal outgrowth Rat cortical neurons were cultured in eight-well chamber slides at a density of 1.18 Â 10 5 cells cm
À2
. The cells were then treated with 10 mM Ab(25-35) for 3 days, followed by addition of the extract, a compound, mouse b-nerve growth factor (NGF) or vehicle (0.1% DMSO). Twelve days later, the cells were fixed by 4% paraformaldehyde, and were immunostained with a monoclonal antibody to phosphorylated NF-H (1:1000) as an axonal marker. Alexa Fluor 488-conjugated goat anti-mouse IgG (1:200) was used as a second antibody. The fluorescence images were captured by a fluorescence microscope (AX-80) at 450 Â 600 mm, and four images were captured per treatment. The lengths of neurites which were positive for phosphorylated NF-H were measured using an image analyzer (Scion Image, Scion, Frederick, MD, USA) for each cell.
Analysis of synaptic formation
Rat cortical neurons were cultured in eight-well chamber slides at a density of 1.18 Â 10 5 cells cm À2 for 28 days. The cells were treated with 10 mM Ab(25-35) for 4 days, and then test compounds were administered. Four days after administration, half of the medium in each well was replaced with fresh medium containing each test compound. Then, 10 days after administration of compounds, the cells were fixed and double-immunostained with a combination of a monoclonal antibody to synaptophysin (1:500) as a presynaptic marker and an antiserum to microtubule-associated protein 2 (MAP2) (1:1000). Alexa Fluor 488-conjugated goat anti-mouse IgG and Alexa Fluor 546-conjugated goat anti-rabbit IgG (1:200) were used as secondary antibodies. The fluorescence images were captured using a confocal laser scanning microscope (Radiance 2100, Bio-Rad, Hercules, CA, USA) at 205 Â 205 mm, and four images were captured per treatment. The area of positive puncta to synaptophysin on each dendrite was measured using an image analyzer (ATTO densitograph, ATTO). The length of the dendrites was measured with Scion Image software (Scion).
Quantifying the content of astragalosides in Astragalus extracts
Each standard astragaloside (10 mg) was accurately weighed into a 10 ml volumetric flask and dissolved in methanol. To obtain calibration curves, a series of standard solutions were prepared from the stock solution and filtered through a 0.2 mm Millipore filter (Advantec, Tokyo, Japan). One gram of methanol extract powder was accurately weighed and dissolved in 50 ml water. After extraction with 20 ml ethyl acetate twice, the aqueous phase was further extracted with 20 ml n-butanol three times. The combined extracts were evaporated and the residue dissolved in 2 ml of 43% aqueous acetonitrile. After filtration through a 0.45 mm Milllipore filter (Advantec), 10 ml was injected into the high-pressure liquid chromatography (HPLC) system for analysis. The JASCO HPLC system (Jasco, Tokyo, Japan) is composed of a CO-1580 intelligent HPLC pump, a DG-1580-53 3-line degaser, a LG-1580-02 ternary gradient unit, a CO-1565 intelligent column oven, an AS-2057 plus intelligent sampler and a MD-1510 diode array detecter. Comparative analysis was carried out using a Mightysil RP-18GP (15 mm, 250 Â 4.6 mm i.d.) with column temperature at 401C. The mobile phase was acetonitrile:water ¼ 43:57. The flow rate was 1.0 ml/min and detection wavelength was 205 nm. The chromatographic data were collected and processed using BORWIN-PDA Application and BORWIN chromatography Software (version 1.5, Jasco).
Cell viability
Viability of cortical neurons was measured by Cell Counting Kit-8 (Dojindo, Kumamoto, Japan).
Statistical analysis
Statistical comparisons were carried out using one-way analysis of variance followed by Dunnett's post hoc test. Values of Po0.05 were considered significant. The means of the data are presented together with the s.e.m.
Materials
The amyloid peptide Ab(25-35) (Sigma, Saint Louis, MO, USA) was dissolved in sterile distilled water at a concentration of 5 mM and 1 mM, respectively, and were incubated at 371C for 4 days to allow fibril formation. Neurobasal media and B-27 supplement were purchased from Gibco BRL (Rockville, MD, USA). Mouse b-NGF was purchased from Astral Biologicals (San Ramon, CA, USA). A monoclonal antibody to phosphorylated NF-H was purchased from Sternberger Monoclonals Incorporated (Lutherville, MD, USA). An antiserum to MAP2 was purchased from Chemicon (Temecula, CA, USA). Alexa Fluor 488-conjugated goat anti-mouse IgG and Alexa Fluor 546-conjugated goat anti-rabbit IgG were purchased from Molecular Probes (Eugene, OR, USA). Astragalosides I, II and IV were isolated from A. mongholicus, and were identified by 1 H-nuclear magnetic resonance (NMR) and 13 C-NMR.
Results
Aqueous extract of A. mongholicus ameliorates the impairment of spatial memory caused by injection of We previously confirmed that neurites and synapses are lost in the hippocampus and cerebral cortex of mice 7 days after the i.c.v. administration of and that the losses continue for at least 14 days (unpublished data). We also confirmed that a spatial memory deficit occurs 14 days after the i.c.v. administration of Ab(25-35) (data not shown). Therefore, mice were given the aqueous extract of A. mongholicus (p.o.) starting 7 days after the i.c.v. administration of , when neuronal and synaptic loss had already begun (see the lower panel of Figure 1 for a schematic
Neuroprotection by A. mongholicus C Tohda et al illustration of the experimental design). The mice continued to receive the extract every day for 7 days, after which the mice were trained in a Morris water maze and continued to receive the extract every day for 7 days. After the training was completed (i.e., 21 days after the i.c.v. administration of the Ab peptide), the mice were subjected to a memory retention test, wherein the number of crossings over the platform position was counted. The number of crossings was significantly lower in the Ab(25-35)-injected mice than the control (saline-treated) mice (upper panel of Figure 1 ). In addition, the number of crossings was significantly higher in the Ab(25-35)-injected mice receiving the A. mongholicus water extract than those receiving vehicle. In contrast, the locomotory activities of the mice did not differ between the groups (data not shown).
Following the memory retention test, we measured the levels of phosphorylated NF-H and synaptophysin in the brains of the mice by immunohistochemistry. We examined two cortical regions (parietal cortex and temporal cortex) and three hippocampal regions (CA1, CA3 and dentate gyrus) which show neuronal degeneration in both Alzheimer's disease patients (DeKosky and Scheff, 1990; Heinonen et al., 1995) and a mouse model of Alzheimer's disease (Games et al., 1995) . We found that, in Ab(25-35)-injected mice, the number of NF-H-positive areas in all regions except for CA3 was higher in extract-treated mice than in vehicle-treated mice ( Figure 2 ). As we reported previously , the dentate gyrus was resistant to Ab(25-35)-induced neuronal loss, although the mechanism of this resistance is not clear. Injection with also reduced the expression of synaptophysin in all five-brain areas (Figure 3b) . Finally, the loss and the synaptic density in Ab(25-35)-injected mice was almost completely reversed by treatment with A. mongholicus extract.
Recovery from axonal atrophy and synaptic loss by treatment with the aqueous extract of A. mongholicus was particularly apparent in the cerebral cortex. Memory retention seems to be related to the consolidation of memory, which is thought to be carried out in the cerebral cortex rather than the hippocampus. Therefore, we next investigated the effects of A. mongholicus on axonal maturation in cortical neurons in vitro.
Methanolic extract of A. mongholicus promotes axonal regeneration in damaged neurons We next examined the effect of methanolic extracts of A. mongholicus on neurite regeneration. Previously, we confirmed that the methanolic and aqueous extracts of A. mongholicus have the same abilities to promote neurite regeneration in rat cortical neurons (data not shown). In this set of experiments, we examined the effect of the methanolic extract. We also compared its effects with the methanolic extract of another type of Astragali Radix, from A. membranaceus. Furthermore, because astragalosides are known to be the main components of the Astragali Radix preparations, we also examined the effects of astragalosides I, II and IV (Figure 4) . We measured the length of neurites after a 5-day treatment of rat cortical neurons with or the test compounds (Figure 5a ). The methanol extract of A. mongholicus (100 mg/ml), astragalosides I, II and IV (100 mM), and NGF (100 ng ml À1 ) all significantly increased the axon length compared with neurons treated with Ab(25-35) alone.
We next examined the ability of the extracts and pure components to promote axonal regeneration after axonal atrophy had already occurred. Therefore, the compounds were administered 3 days after treatment with , and axon lengths were measured after an additional 9 days (Figure 5b ). We found that the axon lengths were shorter in the cells treated with Ab(25-35) followed by vehicle than in control cells. The axon lengths were significantly longer in the Ab(25-35)-treated cells when they were also treated with A. mongholicus extract and astragaloside II than when they were treated with vehicle alone. The extract of A. membranaceus, however, did not significantly enhance the extension of axons when added simultaneously (Figure 5a ) or after treatment with (Figure 5b ). Dose-response experiments indicated that 100 mg/ml of A. mongholicus extract and 100 mM of astragalosides resulted in maximal axonal outgrowth (data not shown).
Synaptic reconstruction in damaged neurons
Determining whether regenerated neurites can also reconstruct synapses is essential. As A. mongholicus extract was able to regenerate axons in Ab(25-35)-treated neurons (Figure 5 ), we next examined its effect on synaptic maturation. Rat cortical neurons were cultured for 28 days to allow development of mature synapses in vitro as described previously (Zhang and Benson, 2001 ). The cultures were treated for 4 days with . After that, cells were treated with test compounds for 10 days. Dendritic shafts were visualized by double-immunostaining with antibodies to synaptophysin and MAP2. Synaptophysin-positive puncta were present at the edge of the dendritic shafts (Figure 6a ). The number and fluorescence intensity of synaptophysin-positive puncta on dendrites was visually decreased by treatment with . Quantification of the area synaptophysinpositive puncta confirmed that Ab(25-35) caused a significant decrease in synapses (59.0% of control; Figure 6b ). These results indicate that caused the loss of synaptic structures in long-term cultured cortical neurons. This was reversed by treatment with A. mongholicus extract and astragaloside I; specifically, the number of synaptophysin-positive puncta was 119 and 94% of control, respectively. The extract from A. membranaceus and NGF had no effect on the synaptic density. Astragalosides II and IV showed similar abilities to promote axonal formation but no effect on synaptic formation. In contrast, astragaloside I enhanced only synaptic formation.
Protection from neuronal death ) is known to induce neuronal cell death, especially in vitro (Yankner et al., 1990) . We therefore investigated the effects of the extracts and astragalosides on cell survival (Figure 7) . Treatment of cortical neurons with 10 mM Ab(25-35) for 3 days caused substantial cell death. Addition of A. mongholicus extract along with Ab(25-35) completely 
Contents of astragalosides in two species of Astragali Radix
We next investigated whether the difference in the effects of the A. mongholicus and A. membranaceus extracts is related to the astragalosides that they contain. We measured the levels of three astragalosides in the methanolic extracts by HPLC. Although there was more astragaloside I in the A. mongholicus extract than the A. membranaceus extract, the levels of astragalosides II and IV were higher in the A. membranaceus extract (Table 1) .
Discussion and conclusions
In the current studies, we have demonstrated for the first time that administration of an aqueous extract of A. mongholicus improved memory deficit induced by in mice. We also found that the extract reversed Ab(25-35)-induced loss of axons and synapses in the cerebral cortex and hippocampus and that it promoted axonal extension and synapse formation in Ab(25-35)-treated cortical neurons. The effects of the extract on axonal extension by cortical neurons were examined using two experimental protocols. We found that the extract of A. mongholicus both prevented Ab(25-35)-induced axonal atrophy (Figure 5a ) and restored axonal outgrowth after atrophy (Figure 5b ). In addition, the extract protected neurons from induced cell death. The extract of another type of Astragali Radix, A. membranaceus, however, did not have a significant effect on neurite atrophy, synaptic loss or cell death.
The major components of Astragali Radix, astragalosides I, II and IV (100 mM), were also effective in the experiments using cortical neurons. Astragaloside I promoted axonal extension, synaptic formation and cell survival; astragaloside II promoted axonal extension; and astragaloside IV promoted axonal extension and cell survival. Each astragaloside was present at a concentration less than 1 mM in 100 mg/ml of A. mongholicus extract. Dose-response experiments, however, showed that astragalosides I, II and IV had weak but not significant effects at doses less than 1 mM (data not shown). In addition, the content of total astragalosides was higher in the extract from A. membranaceus than that from A. mongholicus, although the latter had no activity. We also isolated astraisoflavoneglucoside, astraisoflavanglucoside, astrapterocarpanglucoside and ononin from A. mongholicus to seek other active constituents and assayed their effects on axonal extension, synaptic formation, and cell survival. We found that they had no effect and were present at similar concentrations in the A. membranaceus extract. These results suggest that unidentified components mediate the effects of the A. mongholicus extracts. Current experiments in our laboratory are attempting to identify which are the active compounds.
Although the extract of A. mongholicus inhibited Ab(25-35)-induced neuronal death, this may not be the sole reason . The cells were simultaneously treated with 100 mg ml À1 of the methanolic extract of A. mongholicus (MO) or A. membranaceus (ME); 100 mM of astragalosides I (A I), II (A II) or IV (A IV); 100 ng ml (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) . Three days after the administration of , the cells were treated with 100 mg ml À1 of the methanolic extract of A. mongholicus (MO) or A. membranaceus (ME); 100 mM of astragalosides I (A I), II (A II) or IV (A IV); 100 ng ml À1 of NGF; or vehicle (Veh). Nine days after treatment, the cells were fixed and immunostained with an antibody to phosphorylated NF-H. The lengths of NF-H-positive neurites were measured for each treatment. The results represent the means7s.e.m. of 48-85 cells. *Po0.05 vs Veh.
that the extract promoted axonal extension and synapse formation because the drugs were administered to cells after treatment with when the damage had already occurred . Ab has been reported to induce cell death via a variety of mechanisms (Yamada and Nabeshima, 2000) , but differences in the time courses of cell death and neurite atrophy (Grace et al., 2002) and in Ab formation (Postuma et al., 2000) suggest that Ab induces cell death and neurite atrophy by different mechanisms. As described previously, Ab-induced neurite atrophy is thought to be caused by impaired cell adhesion (Postuma et al., 2000; Grace and Busciglio, 2003) . In addition, Ab causes neurite deformation by interfering with the polymerization and aggregation of actins (Hiruma et al., 2003) . Therefore, different components of A. mongholicus extract may affect cell adhesion, cytoskeletal molecules and cell survival. These multiple activities highlight the advantage of herbal medicines.
The amyloid peptide is not found in brains of patients with Alzheimer's disease. However, several reports support that is an active partial fragment of Ab. This fragment also forms a b-sheet structure (Pike et al., 1995) and induces neuronal cell death (Yankner et al., 1990; Pike et al., 1995) , neuritic atrophy (Grace and Busciglio, 2003; Tohda et al., 2004) and synaptic loss (141-147; Grace and Busciglio, 2003; Tohda et al., 2003 Tohda et al., , 2004 . Also in our Figure 6 Effects of Astragalis extracts or astragalosides on synaptic reconstruction after Ab(25-35)-induced synaptic loss. After culture for 28 days, cortical neurons were treated with or without (Cont) . The cells were then treated with 100 mg ml À1 of methanolic extracts of A. mongholicus (MO) or A. membranaceus (ME); 100 mM astragalosides I (A I), II (A II) or IV (A IV); 100 ng ml À1 NGF; or vehicle (Veh). previous paper, we found that and Ab(1-42) had similar effects on neuritic atrophy and cell death and that 10 mM Ab(1-42) induced the same axonal and dendritic atrophy as 10 mM . The degree of the atrophy induced by Ab(1-42) was not different from that induced by .
In conclusion, we have shown that extracts of A. mongholicus can ameliorate the memory deficit in mice caused by and that they can promote the regeneration of neurites and synapses in the cerebral cortex and hippocampus. These effects were shown only by extracts of A. mongholicus and not by those of A. membranaceus. Although astragalosides and polysaccharides are the most studied biologically active compounds in Astragali Radix, other compounds should be analyzed for their anti-dementia effects. . The cells were simultaneously treated with 100 mg ml À1 of methanolic extract from A. mongholicus (MO) or A. membranaceus (ME); 100 mM of astragalosides I (A I), II (A II) or IV (A IV); 100 ng ml À1 of NGF; or vehicle (Veh). Three days after treatment, cell viability was measured. The results represent the means7s.e.m. of three independent experiments. *Po0.05 vs Veh. Abbreviations: MO, A. mongholicus; ME, A. membranaceus.
